期刊文献+

连续性血液净化治疗终末期肾病难治性高血压临床观察

Continuous blood purification in the treatment of refractory hypertension due to end-stage renal disease
下载PDF
导出
摘要 目的探讨连续性血液净化(CBP)治疗终末期肾病(ESRD)合并难治性高血压(RH)的临床疗效。方法回顾性分析27例ESRD合并RH患者经CBP治疗后血压控制情况及治疗前后血肾素、血管紧张素Ⅱ、甲状旁腺素水平。结果患者治疗后收缩压、舒张压、平均动脉压、血。肾素、血管紧张素Ⅱ、甲状旁腺素水平均较治疗前明显降低,差异有统计学意义(P〈0.05),血压均控制在正常范围。结论CBP为一较好的控制ESRD患者难治性高血压的方法。 Objective To investigate the clinical efficacy of continuous blood purification (CBP) in the treatment of refractory hypertension (RH) in patients with end-stage renal disease (ESRD). Methods The clinical data of the 27 ESRD patients with RH treated by CBP were retrospectively analyzed and the changes in the blood pressure, renin angiotensin (RA), Angiotensin Ⅱ (Ang Ⅱ ), parathyroid hormone (PTH) were observed before and after treatment. Results Mean arterial pressure (MAP), systolic blood pressure (SBP), diastolic blood pressure (DBP) and levels of RA, Ang Ⅱ and PTH after CBP were significantly reduced as compared with those before treatment (P〈0. 05). Conclusion CBP was effective to treat RH in ESRD patients.
出处 《临床肾脏病杂志》 2008年第12期549-551,共3页 Journal Of Clinical Nephrology
关键词 连续性血液净化 终末期肾病 高血压 Continuous blood purification End-stage renal disease Hypertension
  • 相关文献

参考文献12

  • 1Chobanian AV,Bakris GL, Black HR, et al. The Seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report. JA MA, 2003, 289:2560-2572. 被引量:1
  • 2Rahman M, Fu P, Sehgal AR, et al. Interdialytie weight gain, compliance with dialysis regimen, and age are independent pre dictors of blood pressure in hemodialysis patients. Am J Kidney Dis, 2000, 35: 257. 被引量:1
  • 3李世军,姚小丹.慢性肾功能不全高血压的发病机制[J].肾脏病与透析肾移植杂志,2003,12(2):176-180. 被引量:16
  • 4Fishhane S, Natke E, Maesaka JK. Role of volume overload in dialysis-refractory hypertension. Am J Kidney Dis, 1996, 28: 257-261. 被引量:1
  • 5Katzarski KS, Charra B, Luik AJ, et al. Fluid state and blood pressure control in patients treated with long and short haemodialysis. Nephrol Dial Trantsplant, 1999, 14:369-375. 被引量:1
  • 6Locatelli F, Colzani S, DAmico M, et al. Dry weight and sodium balance. Semin Nephrol, 2001, 21: 291-297. 被引量:1
  • 7Grekas D, Bamichas G, Bacharaki D. Hypertension in chronic hemodialysis patients: current view on pathophysiology and treatment. Clin Nephrol, 2000,53:164-168. 被引量:1
  • 8Pizzarelli F, Fabrizi F, Postorino M, et al. Parathyroidectomy and blood pressure inhemodialysis patients. Nephron, 1993, 63: 384-389. 被引量:1
  • 9Rostand SG, Drueke TB. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int, 1999, 56: 383-392. 被引量:1
  • 10Ishikawa Y, Wu LN, Genge BR, et al. Effects of calcitonin and parathyroid hormone on calcification of primary cultures of chicken growth plate chondrocytes. J Bone Miner Res, 1997, 12: 356-366. 被引量:1

二级参考文献52

  • 1杨沐,柴树人,刁秀竹.高血压患者血浆内皮素水平及开搏通对其影响[J].肾脏病与透析肾移植杂志,1995,4(2):119-120. 被引量:2
  • 2陈朝红,刘志红,王庆文,季曙明,季大玺,黎磊石.血管紧张素转化酶基因多态性在终末期肾功能衰竭患者中的分布及其意义[J].中华肾脏病杂志,1997,13(1):22-24. 被引量:15
  • 3[1]Mikhalovsky SV. emerging technologies in extracorporeal treatment:focus on adsorption. Perfusion, 2003,18(7) :47 - 54 被引量:1
  • 4[2]Vanholder R. Review on uremic toxins: Classification, concentration,and interindividual variability. Kidney International,2003,63(5): 1934- 1943 被引量:1
  • 5[3]James F. Removal of Middle Molecules with Sorbents. Artif Cells Blood Substit Immobil Biotechnol, 2002,30(5- 6):547- 554 被引量:1
  • 6[4]Clark WR. Middle molecules and small- molecular- weight protiens in ESRD: Properties and strategies for their removal. Adv Ren Replace Ther,2003, 10(4) :270 - 278 被引量:1
  • 7[5]Morena MD. Effect of novel adsorbent on cytokine responsiveness to uremic plasma. Kidney Int,2003,63(3):1150-4 被引量:1
  • 8[6]Winchester JF. The next step from high - flux dialysis: application of sorbent technology. Blood Purif, 2002,20(1):81-6 被引量:1
  • 9[7]Vanholder R. Survival of hemodialysis patients uremic toxin removal.Artifi Organ,2003,27 (7) :218 - 23 被引量:1
  • 10[9]Schlaeper C. High clearance continuious renal replacement therapy with a modified dialysis machine. Kidney Int Suppl, 1999,72(56): S20 - 3 被引量:1

共引文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部